New Delhi:
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.
"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
COMMENTS
Advertisement
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled" Pfizer Pauses Gene Therapy Trial For Muscle Disease After Death What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine In Massive Row Over Karnataka 100% Quota Bill, Chief Minister Deletes Post Dubai Princess Shaikha Mahra Divorces Husband In Insta Post, Cites Reason 25,000 Aspirants For Airport Jobs Paying Rs 22,000: A Mumbai Stampede Scare "UP Fed Up With Game Of Thrones": Akhilesh Yadav Amid BJP Infighting Buzz Centre Nominates Ex Foreign Secretary As US Ambassador To Secure Ties These Prime Ministers Have Presented Budget Instead Of Finance Ministers Track Latest News Live on NDTV.com and get news updates from India and around the world.